Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

By sjmartinez • February 15, 2023

Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hébert PC; MINT Investigators. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. Am Heart J. 2023 Mar;257:120-129. doi: 10.1016/j.ahj.2022.11.015. Epub 2022 Nov 20. PMID: 36417955; PMCID: PMC9928777.

Tags: Cardiology/Epi, Publications, Veterans Administration

Atrial Fibrillation and Cancer: Bidirectional Relationship and Potential for Personalized Care

Grewal US, Byer SH, Mahajan S, Sheth AR, Beedupalli K, Fradley MG, Yang EH, Russo AM, Asnani A, Dominic P. Atrial Fibrillation and Cancer: Bidirectional[...]

Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial

Lookstein RA, Konstantinides SV, Weinberg I, Dohad SY, Rosol Z, Kopeć G, Moriarty JM, Parikh SA, Holden A, Channick RN, McDonald B, Nagarsheth KH, Yamada[...]

Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with inherited cardiomyopathies

Sarkar A, Pisciotti SL, Tapias C, Assis F, Tandri H, Wang J, Chrispin J, Syed F, Yanagawa J, Lee J, Bradfield JS, Shivkumar K, Saenz[...]